MEDONEFARMA

COPANLISIB HCL (LYO)

PRODUCT DESCRIPTION

Copanlisib is a phosphatidylinositol 3-kinase (PI3K) inhibitor that’s given intravenously. It used to treat relapsed follicular lymphoma (FL), a slow-growing blood cancer

CHEMICAL NAME

5-pyrimidinecarboxamide, 2-amino-N-(2,3-dihydro-7-methoxy-8-(3-(4-morpholinyl)propoxy)imidazo(1,2-C)quinazolin-5-yl)-, hydrochloride (1:2)

Brand Names

Aliqopa, Copanlisib

Category

Oncology (PI3K inhibitor)

DOSAGE FORM

Injection: 60 mg of copanlisib as a lyophilized solid in single-dose vial for reconstitution.

INDICATIONS

  • It is for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies.
  • For Gastric MALT lymphoma (extranodal marginal zone lymphoma of the stomach)

NDC CODE

50419-385-01

STORAGE & SHELF LIFE

  • Shelf life: 3 years (36 months) Unopened
  • Protected from air and light, refrigerate or freeze(2-8 °C). 

Anti-infectives

Order Online
55 9262-4298

Can’t find what you are looking for?

Please call us. We would love to help.
Contact US